Form 4: Ventas EVP and CFO Exercises Stock Options and Sells Shares Under Pre-Arranged Trading Plan

Ventas, Inc.'s Executive Vice President and Chief Financial Officer, Robert F. Probst, exercised stock options and subsequently sold the acquired shares as part of a pre-established Rule 10b5-1 trading plan.

Summary

• Robert F. Probst, Executive Vice President and Chief Financial Officer of Ventas, Inc. (VTR), executed a pre-planned transaction on May 27, 2025.
• He exercised 17,374 fully vested stock options at an exercise price of $62.22 per share.
• Concurrently, he sold 17,374 shares of Ventas common stock at a weighted average price of $65.2204 per share.
• This transaction was conducted pursuant to a Rule 10b5-1 trading plan that Mr. Probst entered into on February 19, 2025.
• Following these transactions, Mr. Probst directly holds 168,364 shares of common stock and 269,091 unexercised stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it's an insider sale, it's pre-planned under a 10b5-1 plan, which reduces negative implications. The executive also profited from the transaction, indicating value realization from compensation.

Positives

• The transaction was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled, non-discretionary sale, which typically mitigates concerns about insider selling.
• The sale price of $65.2204 per share was higher than the exercise price of $62.22 per share, indicating a profit for the executive on the exercised options.

Negatives

• The sale of shares by an executive, even if pre-planned, results in a reduction of their direct equity ownership in the company.

Risks

• No specific risks related to company operations, financial health, or future performance are mentioned in this Form 4 filing, as its primary purpose is to report insider transactions.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook, as its purpose is solely to report insider transactions.

Management Comments

• The transaction involved the exercise of fully vested options scheduled to expire in the next 20 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025.

Industry Context

This filing is specific to an individual executive's equity transactions and does not provide broader industry context or trends. It reflects a routine executive compensation-related activity within the real estate investment trust (REIT) sector, specifically for Ventas, Inc., a healthcare REIT.

Comparison to Industry Standards

• This Form 4 filing reports a standard insider transaction (exercise and sale of options) under a Rule 10b5-1 plan, which is a common practice for executives to manage their equity holdings and diversify their portfolios in a compliant manner.
• There are no specific comparable companies, projects, or results mentioned within this document to assess against industry standards, as it focuses on an individual's stock activity rather than company performance.

Stakeholder Impact

• Shareholders: The transaction represents a minor reduction in the direct equity stake of a key executive, but it was pre-planned and not indicative of a lack of confidence.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• No specific future actions, events, or milestones for the company are mentioned in this Form 4 filing, as it pertains to an individual's past transaction.

Key Dates

Recommendation

Keywords

Ventas Inc, VTR, Form 4, Insider Trading, Stock Options, Rule 10b5-1, Executive Compensation, Share Sale, Beneficial Ownership